Delphine Bertrand

866 total citations
41 papers, 506 citations indexed

About

Delphine Bertrand is a scholar working on Rheumatology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Delphine Bertrand has authored 41 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Rheumatology, 17 papers in Hematology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Delphine Bertrand's work include Rheumatoid Arthritis Research and Therapies (33 papers), Autoimmune and Inflammatory Disorders Research (17 papers) and Systemic Lupus Erythematosus Research (11 papers). Delphine Bertrand is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (33 papers), Autoimmune and Inflammatory Disorders Research (17 papers) and Systemic Lupus Erythematosus Research (11 papers). Delphine Bertrand collaborates with scholars based in Belgium, Netherlands and France. Delphine Bertrand's co-authors include Sandy Lacombe, Benoît Colinet, William Jacot, Patrick Verschueren, René Westhovens, Sofia Pazmiño, Diederik De Cock, Daurès Jp, Veerle Stouten and Johan Joly and has published in prestigious journals such as British Journal of Cancer, Annals of Oncology and Annals of the Rheumatic Diseases.

In The Last Decade

Delphine Bertrand

35 papers receiving 498 citations

Peers

Countries citing papers authored by Delphine Bertrand

Since Specialization

Citations

This map shows the geographic impact of Delphine Bertrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Delphine Bertrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Delphine Bertrand more than expected).

Fields of papers citing papers by Delphine Bertrand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Delphine Bertrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Delphine Bertrand. The network helps show where Delphine Bertrand may publish in the future.

Co-authorship network of co-authors of Delphine Bertrand

This figure shows the co-authorship network connecting the top 25 collaborators of Delphine Bertrand. A scholar is included among the top collaborators of Delphine Bertrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Delphine Bertrand. Delphine Bertrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effectiveness and patient-reported impact of on-flare retreatment in patients with rheumatoid arthritis: insights from retrospective long-term real-world data 2025 ·BMC Rheumatology ·Delphine Bertrand, (unknown), (unknown), Diederik De Cock, Johan Joly, Barbara Neerinckx, Sofia Pazmiño, (unknown), (unknown), René Westhovens, Patrick Verschueren	0
2	Treat-to-target fixed dose rituximab retreatment versus fixed interval retreatment with disease activity-guided rituximab dose optimisation for patients with rheumatoid arthritis: study protocol for a multicentre randomised controlled superiority trial focusing on long-term disease impact (RITUXERA) 2024 ·Trials ·(unknown), Delphine Bertrand, Johan Joly, (unknown), (unknown), (unknown), Barbara Neerinckx, René Westhovens, Patrick Verschueren	1
3	A mobile app to support self-management and remotely monitor disease impact in rheumatoid arthritis: the randomized controlled AEGORA trial 2024 ·Lara D. Veeken ·(unknown), (unknown), Delphine Bertrand, Sofia Pazmiño, (unknown), Johan Joly, (unknown), René Westhovens, Patrick Verschueren	1
4	AB0525 EARLY RESPONDERS TO REMISSION-INDUCTION TREATMENT WITH METHOTREXATE AND BRIDGING GLUCOCORTICOIDS REPORT LOWER RHEUMATOID ARTHRITIS IMPACT OF DISEASE (RAID) OVER 2 YEARS: SECONDARY ANALYSIS OF THE CARERA2020 TRIAL 2024 ·Annals of the Rheumatic Diseases ·(unknown), Delphine Bertrand, (unknown), (unknown), Sofia Pazmiño, (unknown), (unknown)	0
5	Patients' and rheumatologists' perceptions on dose reduction of rituximab in rheumatoid arthritis 2024 ·Musculoskeletal Care ·Delphine Bertrand, (unknown), (unknown), Diederik De Cock, Sofia Pazmiño, (unknown), (unknown), Johan Joly, (unknown), Barbara Neerinckx, René Westhovens, Patrick Verschueren	1
6	Definitions of rheumatoid arthritis flare and how they relate to patients’ perspectives: A scoping review of qualitative and quantitative evidence 2024 ·Seminars in Arthritis and Rheumatism ·(unknown), (unknown), (unknown), Delphine Bertrand, (unknown), René Westhovens, Patrick Verschueren	2
7	POS0327 SPEED OF RESPONSE MATTERS: POST-HOC ANALYSIS OF PATIENTS WITH EARLY SERONEGATIVE RHEUMATOID ARTHRITIS INCLUDED IN THE CARERA TRIAL 2023 ·Annals of the Rheumatic Diseases ·Sofia Pazmiño, René Westhovens, Veerle Stouten, Delphine Bertrand, (unknown), Johan Joly, (unknown), (unknown), Patrick Verschueren	0
8	Effectiveness and feasibility of a mobile health self-management intervention in rheumatoid arthritis: study protocol for a pragmatic multicentre randomised controlled trial (AEGORA) 2023 ·Trials ·(unknown), (unknown), (unknown), Sofia Pazmiño, Johan Joly, Delphine Bertrand, (unknown), René Westhovens, Patrick Verschueren	3
9	New indicator for discordance between patient-reported and traditional disease activity outcomes in patients with early rheumatoid arthritis 2022 ·Lara D. Veeken ·Sofia Pazmiño, Anikó Lovik, Annelies Boonen, Diederik De Cock, Veerle Stouten, Johan Joly, (unknown), Delphine Bertrand, René Westhovens, Patrick Verschueren	8
10	Glucocorticoids in rheumatoid arthritis: Balancing benefits and harm by leveraging the therapeutic window of opportunity 2022 ·Joint Bone Spine ·(unknown), Sofia Pazmiño, Delphine Bertrand, René Westhovens, Patrick Verschueren	13
11	Psychological stress in rheumatoid arthritis: a systematic scoping review 2022 ·Seminars in Arthritis and Rheumatism ·Diederik De Cock, (unknown), (unknown), (unknown), Delphine Bertrand, Sofia Pazmiño, René Westhovens, Patrick Verschueren	11
12	Longitudinal trajectories of fatigue in early RA: the role of inflammation, perceived disease impact and early treatment response 2022 ·Annals of the Rheumatic Diseases ·(unknown), Sofia Pazmiño, Delphine Bertrand, Diederik De Cock, Johan Joly, René Westhovens, Patrick Verschueren	9
13	POS1434 WHICH PROGNOSTIC FACTORS MIGHT PREDICT THE NEED FOR TREATMENT ADAPTATION IN EARLY RHEUMATOID ARTHRITIS? A COMPARISON OF MACHINE LEARNING, SURVIVAL ANALYSIS AND REGRESSION METHODS 2021 ·Annals of the Rheumatic Diseases ·(unknown), Tim Verdonck, Sofia Pazmiño, Veerle Stouten, Delphine Bertrand, (unknown), René Westhovens, Patrick Verschueren, Diederik De Cock	1
14	Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial 2021 ·Annals of the Rheumatic Diseases ·Veerle Stouten, René Westhovens, Sofia Pazmiño, Diederik De Cock, Kristien Van der Elst, Johan Joly, Delphine Bertrand, Patrick Verschueren	21
15	Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis 2021 ·Arthritis Research & Therapy ·(unknown), Diederik De Cock, Sofia Pazmiño, Delphine Bertrand, Johan Joly, René Westhovens, Patrick Verschueren	18
16	THU0093 EARLY REMISSION IS ASSOCIATED WITH LOWER FATIGUE LEVELS ON THE LONG TERM IN PATIENTS WITH RECENT ONSET RHEUMATOID ARTHRITIS 2020 ·Annals of the Rheumatic Diseases ·Diederik De Cock, (unknown), Delphine Bertrand, Veerle Stouten, Sofia Pazmiño, Johan Joly, René Westhovens, Patrick Verschueren	1
17	Does Including Pain, Fatigue, and Physical Function When Assessing Patients with Early Rheumatoid Arthritis Provide a Comprehensive Picture of Disease Burden? 2020 ·The Journal of Rheumatology ·Sofia Pazmiño, Anikó Lovik, Annelies Boonen, Diederik De Cock, Veerle Stouten, Johan Joly, Delphine Bertrand, Kristien Van der Elst, René Westhovens, Patrick Verschueren	9
18	Management of forearm bone loss with induced membrane technique 2020 ·Hand surgery & rehabilitation ·(unknown), François Loisel, Delphine Bertrand, (unknown), Florelle Gindraux, (unknown), D. Lepage, (unknown), Grégoire Leclerc, (unknown), P. Garbuio, Laurent Obert, I. Pluvy	12
19	Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients 2008 ·Annals of Oncology ·William Jacot, Benoît Colinet, Delphine Bertrand, Sandy Lacombe, (unknown), J.P. Daurès, Jean-Louis Pujol	83
20	A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index 2005 ·British Journal of Cancer ·(unknown), Benoît Colinet, William Jacot, Delphine Bertrand, Sandy Lacombe, (unknown), Daurès Jp, (unknown)	168

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact